Drug pricing reform will threaten pharmaceutical industry

The Korea Pharmaceutical Manufacturers Association (KPMA) said Monday that the country’s pharmaceutical sector could lose up to 1.5 trillion won until 2012 if the government is to implement reform on the pricing of drugs with potential price slashes both innovative and generic drugs.

In a recent seminar, KPMA chairman Lee Kyung-ho noted that the price reform is likely to have significant imp...